Listen on the go
CORRECT!
Next question
touchENDOCRINOLOGY touchENDOCRINOLOGY

Start Learning

Touch Loading image
Eneboparatide meets primary endpoint in adults with hypoparathyroidism: CALYPSO topline phase III results
JOURNALS
Start Learning
Eneboparatide meets primary endpoint in adults with hypoparathyroidism: CALYPSO topline phase III results
touchMEETING HIGHLIGHTS
Start Learning
Spotlight on clinical management of growth hormone disorders through AI & digital innovation
Sponsored content
touchMDT
Start Learning
Navigating diagnosis, monitoring, and early treatment in achondroplasia: Multidisciplinary insights from specialist obstetricians and paediatricians
CE/CME ACCREDITED
touchCONGRESS
Start Learning
Expanding horizons for patients with Pompe disease: Using data to guide clinical practice
CE/CME ACCREDITED
JOURNALS
Start Learning
The Approach to Patients with Disorders of Sex Development (DSD) in the Era of Precision Medicine: The Careful Use of Terminology
Human Internal Digestive Organs Pancreas with Gallbladder Anatomy
JOURNALS
Start Learning
Efficacy and Safety of Early Initiation of Sodium–Glucose Co-transporter-2 Inhibitors Following Acute Myocardial Infarction: A Systematic Review and Meta-analysis
Research highlights disparities in liver transplants for non-cancer conditions
JOURNALS
Start Learning
Low anti-Müllerian hormone levels tied to fatty liver risk in women: Findings from the CARDIA study
JOURNALS
Start Learning
EASD 2024: The latest in vascular endocrinology – insights from the late-breaking session ‘Ailing Heart, Broken Vessels’
JOURNALS
Start Learning
Building a legacy: Dr Sanjay Kalra’s endocrinology journey
touchMDT
Start Learning
Navigating the management of cholestatic pruritus in patients with PBC: Insights from the multidisciplinary team
CE/CME ACCREDITED

to view Favourites, Keep Notes and Track CME Credits

Favourites
Benefits of finerenone for patients with type 2 diabetes, cardiovascular, kidney and metabolic complications
View
Expanding horizons for patients with Pompe disease: Using data to guide clinical practice
View
Foreword: touchREVIEWS in Endocrinology 20.2
View
Primary biliary cholangitis: Appraising the changing therapeutic landscape
View
MiniMed 780G safe and effective for children 2-6 years with type 1 diabetes
View
Glucocorticoid-induced adrenal insufficiency
View
Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
View
Trending at #ADA2024
View
Liraglutide safe and effective to treat obesity in children under 12 years
View
What to expect from IDS 2024?
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup